Pharmacologic management of hepatic encephalopathy includes a broad range of therapies. This article covers the specific mainstays of therapies, such as antimicrobials and laxatives, with an established evidence base. This article also covers newer modalities of therapies, such as fecal microbiota transplant, probiotics, bioartificial support systems, small molecular therapies such as L-ornithine L-aspartate, branched chain amino acids, L-carnitine, zinc, and other forms of therapy currently under review.
All Science Journal Classification (ASJC) codes
- Branched chain amino acid
- L-ornithine L-aspartate
- Ornithine phenylacetate